Cited by 29Dementia and Cognitive Impairment ResearchHealthcare Policy and ManagementHealth Systems, Economic Evaluations, Quality of Life

Out‐of‐pocket costs attributable to dementia: A longitudinal analysis

Open access
Oney, Melissa, White, Lindsay, Coe, Norma B.·2022·Journal of the American Geriatrics Society

Abstract

Background: Alzheimer's disease and related dementias (ADRD) affect 5.7 million Americans, and are expensive despite the lack of a cure or even treatments effective in managing the disease. The literature thus far has tended to focus on the costs to Medicare, even though one of the main characteristics of ADRD (the loss of independence and ability to care for oneself) incurs costs not covered by Medicare. Methods: In this paper, we use survey data for 2002–2016 from the Health and Retirement Study to estimate the out‐of‐pocket costs of ADRD for the patient and their family through the first 8 years after the onset of symptoms, as defined by a standardized 27‐point scale of cognitive ability. A two‐part model developed by Basu and Manning (2010) allows us to separate the costs attributable to ADRD into two components, one driven by differences in longevity and one driven by differences in utilization. Results: We identified a cohort of 3619 incident dementia cases, 38.9% were male, and 66.9% were non‐Hispanic White. Dementia onset was 77.7 years of age, on average. OOP costs attributable to dementia are $8751 over the first 8 years after the onset. These incremental costs are driven by nursing home expenditures, which are largely uninsured in the US. OOP spending is highest for whites and women. Conclusion: The financial burden of ADRD is significant, and largely attributable to the lack of wide‐spread long‐term care insurance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgs.17746

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Out-of-pocket costs for Alzheimer's and other dementias have been shown to increase over time, from $3,104 in the first two years after diagnosis to $3,730 in years three to four, to $3,934 in years seven to eight (2017 dollars; $3,579, $4,300, and $4,535 in 2023 dollars).

    “Although incremental Medicare expenditures peak in the year after diagnosis and decrease in the subsequent four years, out‐of‐pocket costs have been shown to increase over time, from $3,104 in the first two years after diagnosis to $3,730 in years three to four after diagnosis, to $3,934 in years seven to eight after diagnosis (in 2017 dollars; $3,579, $4,300 and $4,535 in 2023 dollars). 865”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [865]

    The Results report that out-of-pocket spending for people with dementia fell from $7,506 in the first two years after symptom onset to $3,630 in years seven and eight. The Discussion likewise says costs were highest around symptom onset and declined thereafter. The cited paper does not support the claimed increase or its dollar figures; it measures time from symptom onset, not diagnosis. (LLM, conf=0.92)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]Gay B, Katz R, Johnson JH. Preparing for LTC Financing Reform. How Can Racial Disparities Be Addressed? Generations: Journal of the American Society on Aging 2019; 43: 60– 6.

Cited by

Sorted by citations

Authors
Oney, M., White, L., & Coe, N. B.
Affiliations
  • University of Pennsylvania (US)
  • RTI International (US)
  • Leonard Davis Institute of Health Economics (US)
Corresponding author
Oney, Melissa
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2022-03-12
Volume
70
Issue
5
Pages
1538-1545
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W4221023005
Cited by
29
References
25
Citations by year
2026: 3 · 2025: 12 · 2024: 7 · 2023: 6 · 2022: 1
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Geriatrics Society (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (R01AG049815)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
Alzheimer's disease and related dementias, dementia, out-of-pocket costs, financial burden, long-term care insurance, Medicare, health care utilization, longevity, Health and Retirement Study
MeSH terms
Aged, Alzheimer Disease, Ethnicity, Health Expenditures, Female, Medicare, Humans, Male, Nursing Homes, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review